Urine Tuberculosis Lipoarabinomannan Predicts Mortality in Hospitalized Human Immunodeficiency Virus-Infected Children
Year: 2018
Type: article
Study design: Observational Study
Abstract: Despite diagnostic performance limitations, urine lipoarabinomannan (LAM) predicts death in human immunodeficiency virus (HIV)–infected adults with tuberculosis. Pediatric data are limited. Among 137 hospitalized HIV-infected children, mortality was 4.9-fold higher among those with positive LAM (127 vs 31 per 100 person-years; adjusted hazard ratio, 4.92; 95% confidence interval [CI], 1.79–13.49; P = .002). Lipoarabinomannan identifies HIV-infected children at risk for death potentially missed by respiratory sampling. NCT02063880.
Source: Clinical Infectious Diseases
DOI: 10.1093/cid/ciy011
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: Firland Foundation, National Institutes of Health, Center for AIDS Research, University of Washington, National Institute of Allergy and Infectious Diseases, Fogarty International Center, National Institute of Child Health and Human Development, National Center for Advancing Translational Sciences, Eunice Kennedy Shriver National Institute of Child Health and Human Development
Awards: G1211141729, G1389856746, G1898711858, G2213881162, Impact of maternal HIV on Mycobacterium tuberculosis infection among peripartum women and their infants, G3435361946, G378552126, G627155725, G691201058, G9000009745, G9000070302, G9000088351, G9000132270, G9000158781, STD and AIDS Research Training Grant
OpenAlex ID: W2782128398
